Abstract
OBJECTIVE--To assess whether the combined measles, mumps, and rubella vaccine increases the incidence of joint and limb symptoms in young children. DESIGN--Comparison of six week recalled incidence of symptoms in two groups of children: children who had been immunised at the start of the six weeks, and children eligible for immunisation but who had not received it. SETTING--South Manchester Health Authority. SUBJECTS--2658 children immunised during July 1989-February 1990 and 2359 not yet immunised. Questionnaires were returned for 1846 immunised children and 1075 not immunised. MAIN OUTCOME MEASURE--Recalled rate of joint and limb episodes determined by postal questionnaire and later by clinical follow up. RESULTS--Compared with non-immunised children the immunised group had an increased incidence of new episodes (relative risk 1.6 (95% confidence interval (1.2 to 2.1)) and first ever episodes, though this was not significant (1.7 (0.3 to 3.5)). The risk of first episodes was increased in girls (3.5 (1.1 to 12.2)) but not in boys (1.0 (0.4 to 2.6)). Similarly, an increased risk was seen in children aged under 5 (12.0 (1.6 to 92.3)) but not in older children (0.7 (0.3 to 1.5)). Most episodes were mild and self limiting, but three immunised children required hospital referral. CONCLUSION--Measles, mumps, and rubella vaccine is associated with an increased risk of episodes of joint and limb symptoms, especially in girls and children under 5. The risk of frank arthritis is substantially less than after wild rubella infection.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Balfour H. H., Jr, Balfour C. L., Edelman C. K., Rierson P. A. Evaluation of Wistar RA27/3 rubella virus vaccine in children. Am J Dis Child. 1976 Oct;130(10):1089–1091. doi: 10.1001/archpedi.1976.02120110051006. [DOI] [PubMed] [Google Scholar]
- Fry J., Dillane J. B., Fry L. Rubella, 1962. Br Med J. 1962 Sep 29;2(5308):833–834. doi: 10.1136/bmj.2.5308.833. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hildebrandt H. M., Maassab H. F. Rubella synovitis in a one-year-old patient. N Engl J Med. 1966 Jun 23;274(25):1428–1430. doi: 10.1056/NEJM196606232742507. [DOI] [PubMed] [Google Scholar]
- LASS R., SHEPHARD E. Mumps arthritis. Br Med J. 1961 Dec 16;2(5267):1613–1614. doi: 10.1136/bmj.2.5267.1613. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Miller C., Miller E., Rowe K., Bowie C., Judd M., Walker D. Surveillance of symptoms following MMR vaccine in children. Practitioner. 1989 Jan;233(1461):69–73. [PubMed] [Google Scholar]
- Peltola H., Heinonen O. P. Frequency of true adverse reactions to measles-mumps-rubella vaccine. A double-blind placebo-controlled trial in twins. Lancet. 1986 Apr 26;1(8487):939–942. doi: 10.1016/s0140-6736(86)91044-5. [DOI] [PubMed] [Google Scholar]
- Preblud S. R. Some current issues relating to rubella vaccine. JAMA. 1985 Jul 12;254(2):253–256. [PubMed] [Google Scholar]
- Spruance S. L., Smith C. B. Joint complications associated with derivatives of HPV-77 rubella virus vaccine. Am J Dis Child. 1971 Aug;122(2):105–111. doi: 10.1001/archpedi.1971.02110020039002. [DOI] [PubMed] [Google Scholar]
- Tingle A. J., Allen M., Petty R. E., Kettyls G. D., Chantler J. K. Rubella-associated arthritis. I. Comparative study of joint manifestations associated with natural rubella infection and RA 27/3 rubella immunisation. Ann Rheum Dis. 1986 Feb;45(2):110–114. doi: 10.1136/ard.45.2.110. [DOI] [PMC free article] [PubMed] [Google Scholar]